HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donald Banerji Selected Research

Glycopyrrolate (Glycopyrronium Bromide)

1/2019Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.
1/2018Indacaterol/glycopyrronium: a dual bronchodilator for COPD.
1/2018Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.
1/2018Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.
1/2018Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.
12/2017Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
8/2017Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program.
1/2017Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.
1/2017The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD.
1/2017Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donald Banerji Research Topics

Disease

43Chronic Obstructive Pulmonary Disease (COPD)
04/2020 - 06/2011
5Dyspnea (Shortness of Breath)
08/2017 - 01/2012
5Obstructive Lung Diseases (Obstructive Lung Disease)
01/2017 - 06/2011
4Pneumonia (Pneumonitis)
01/2017 - 10/2014
4Asthma (Bronchial Asthma)
01/2008 - 09/2005
2Allergic Rhinitis
05/2006 - 01/2003
1Eosinophilia
11/2017
1Cough
01/2015
1Atrial Flutter (Flutter, Atrial)
10/2014
1Perennial Allergic Rhinitis
05/2006
1Inflammation (Inflammations)
09/2005

Drug/Important Bio-Agent (IBA)

34Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
01/2019 - 06/2011
29indacaterolIBA
01/2019 - 01/2012
18Muscarinic AntagonistsIBA
01/2018 - 06/2011
17Bronchodilator Agents (Bronchodilators)IBA
01/2018 - 06/2011
15Fluticasone (Cutivate)FDA LinkGeneric
01/2018 - 01/2003
14indacaterol-glycopyrronium combinationIBA
11/2015 - 01/2013
13Salmeterol Xinafoate (Serevent)FDA Link
01/2018 - 03/2013
12Tiotropium Bromide (Spiriva)FDA Link
01/2018 - 06/2011
12Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 09/2005
5GoldIBA
01/2016 - 01/2013
4ciclesonideFDA Link
01/2008 - 09/2005
3Fluticasone-Salmeterol Drug Combination (Advair)FDA Link
01/2019 - 01/2016
3vilanterolIBA
12/2017 - 06/2014
3GSK573719IBA
12/2017 - 06/2014
2SteroidsIBA
05/2006 - 09/2005
2Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
05/2006 - 01/2003
1Indicators and Reagents (Reagents)IBA
01/2018
1maleic acid (maleate)IBA
12/2017
1BromidesIBA
12/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1GlucocorticoidsIBA
01/2016
1Pharmaceutical PreparationsIBA
01/2016
1omega-Chloroacetophenone (Mace)IBA
10/2014
1fluticasone furoateFDA Link
06/2014
1PowdersIBA
12/2011
1Nasal SpraysIBA
05/2006
1norflurane (R 134a)IBA
05/2006
1Prednisone (Sone)FDA LinkGeneric
05/2006
1Albuterol (Salbutamol)FDA LinkGeneric
12/2005

Therapy/Procedure

10Therapeutics
04/2020 - 12/2005
1Nebulizers and Vaporizers (Inhaler)
01/2018